Lincoln Pharmaceuticals Share Price

564.35-2.40 (-0.43%)
Volume: 19,358

Closed
Last Updated On: 08 May, 2025, 03:47 PM IST

STOCK SCORE

ETPrime Only

564.35-2.40 (-0.43%)
Volume: 19,358

Lincoln Pharma share price insights

View All

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 17.72% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 78.82% as compared to Nifty Smallcap 100 which gave a return of 71.75%. (as of last trading session)
Increase in Cash from Investing
Company has used Rs 57.34 cr for investing activities which is an YoY increase of 56.49%. (Source: Consolidated Financials)
Stock Returns vs Nifty Pharma
Stock generated 78.82% return as compared to Nifty Pharma which gave investors 67.4% return over 3 year time period. (as of last trading session)
Lincoln Pharma Share Price Update
Lincoln Pharmaceuticals Ltd. share price moved down by -0.43% from its previous close of Rs 566.75. Lincoln Pharmaceuticals Ltd. stock last traded price is 564.35
Share Price Value
Today/Current/Last 564.35560.90
Previous Day 566.75567.40

Share Price	Value
Today/Current/Last	564.35560.90
Previous Day	566.75567.40

InsightsLincoln Pharma

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

12.65

EPS - TTM

(₹)

44.62

MCap

(₹ Cr.)

1,130.38

Sectoral MCap Rank

PB Ratio

(x)

1.91

Div Yield

(%)

0.32

Face Value

(₹)

10.00

Beta

1.85

VWAP

(₹)

568.82

52W H/L

(₹)

979.50 / 499.00

Lincoln Pharma Share Price Returns

1 Day	-0.43%
1 Week	-0.56%
1 Month	4.18%
3 Months	-24.67%
1 Year	-1.09%
3 Years	76.41%
5 Years	286.28%

ET Stock ScreenersTop Score Companies

Check whether Lincoln Pharma belongs to analysts' top-rated companies list?

View Stock Screeners

Lincoln Pharma News & Analysis

View all Lincoln Pharma Share News & Announcements

Lincoln Pharma Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Lincoln Pharma Share Recommendations

Recent Recos

BUY

Current

Mean Recos by 1 Analysts

Strong
SellSellHoldBuyStrong
Buy

That's all for Lincoln Pharma recommendations. Check out other stock recos.

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	-	-	-	-
Buy	1	1	1	1
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	1	1

View all Stock Recommendations

Lincoln Pharma Financials

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 17.72% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	155.52	171.19	157.69	149.51	157.47
Total Income Growth (%)	-9.15	8.56	5.47	-5.05	-4.38
Total Expenses	126.11	136.06	127.77	126.80	119.60
Total Expenses Growth (%)	-7.31	6.48	0.77	6.01	-6.14
EBIT	29.41	35.13	29.92	22.72	37.87
EBIT Growth (%)	-16.29	17.43	31.70	-40.01	1.62
Profit after Tax (PAT)	20.77	26.33	23.67	18.60	28.04
PAT Growth (%)	-21.12	11.23	27.29	-33.68	1.40
EBIT Margin (%)	18.91	20.52	18.97	15.19	24.05
Net Profit Margin (%)	13.35	15.38	15.01	12.44	17.81
Basic EPS (₹)	10.37	13.15	11.82	9.28	14.00

Quarterly \| Annual	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	155.52	171.19	157.69	149.51	157.47
Total Income Growth (%)	-9.15	8.56	5.47	-5.05	-4.38
Total Expenses	126.11	136.06	127.77	126.80	119.60
Total Expenses Growth (%)	-7.31	6.48	0.77	6.01	-6.14
EBIT	29.41	35.13	29.92	22.72	37.87
EBIT Growth (%)	-16.29	17.43	31.70	-40.01	1.62
Profit after Tax (PAT)	20.77	26.33	23.67	18.60	28.04
PAT Growth (%)	-21.12	11.23	27.29	-33.68	1.40
EBIT Margin (%)	18.91	20.52	18.97	15.19	24.05
Net Profit Margin (%)	13.35	15.38	15.01	12.44	17.81
Basic EPS (₹)	10.37	13.15	11.82	9.28	14.00

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	614.97	532.78	482.12	429.85	397.53
Total Revenue Growth (%)	15.43	10.51	12.16	8.13	6.91
Total Expenses	492.73	432.30	386.18	346.13	330.30
Total Expenses Growth (%)	13.98	11.94	11.57	4.79	6.67
Profit after Tax (PAT)	93.30	72.90	69.36	62.22	51.44
PAT Growth (%)	27.99	5.11	11.46	20.97	5.60
Operating Profit Margin (%)	21.30	20.08	20.62	20.10	17.91
Net Profit Margin (%)	16.07	14.28	14.69	14.66	13.30
Basic EPS (₹)	46.58	36.40	34.63	31.11	25.72

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	614.97	532.79	482.08	419.82	388.22
Total Revenue Growth (%)	15.42	10.52	14.83	8.14	7.95
Total Expenses	492.73	432.34	386.15	338.81	324.17
Total Expenses Growth (%)	13.97	11.96	13.97	4.51	7.53
Profit after Tax (PAT)	93.30	72.90	69.36	60.41	49.56
PAT Growth (%)	27.99	5.11	14.81	21.88	6.28
Operating Profit Margin (%)	21.30	20.08	20.62	19.96	17.55
Net Profit Margin (%)	16.07	14.28	14.69	14.62	13.17
Basic EPS (₹)	46.58	36.40	34.63	30.20	24.78

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	700.29	587.42	534.36	459.37	389.39
Total Assets Growth (%)	19.21	9.93	16.32	17.97	6.61
Total Liabilities	107.45	84.95	101.48	83.67	75.92
Total Liabilities Growth (%)	26.50	-16.29	21.28	10.22	-20.54
Total Equity	592.84	502.47	432.88	375.70	313.47
Total Equity Growth (%)	17.98	16.08	15.22	19.85	16.23
Current Ratio (x)	4.84	5.08	3.90	4.17	3.78
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.01
Contingent Liabilities	1.12	2.68	2.47	7.31	2.37

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	700.15	587.26	534.11	438.69	367.21
Total Assets Growth (%)	19.22	9.95	21.75	19.47	5.89
Total Liabilities	107.31	84.78	101.24	73.74	62.71
Total Liabilities Growth (%)	26.57	-16.26	37.29	17.59	-25.50
Total Equity	592.84	502.47	432.88	364.95	304.49
Total Equity Growth (%)	17.99	16.08	18.61	19.86	15.95
Current Ratio (x)	4.85	5.09	3.91	4.17	3.88
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.01
Contingent Liabilities	1.12	2.68	2.47	7.28	2.26

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 63.22 cr is 0.68 times compared to the reported net profit of Rs 93.3 cr. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 57.34 cr for investing activities which is an YoY increase of 56.49%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	63.22	39.26	76.13	69.27	75.42
Net Cash used in Investing Activities	-57.34	-36.64	-78.08	-64.23	-30.88
Net Cash flow from Financing Activities	-5.18	-4.50	-2.56	-5.75	-37.76
Net Cash Flow	0.70	-1.88	-4.50	-0.70	6.77
Closing Cash & Cash Equivalent	5.75	5.05	6.93	11.44	12.23
Closing Cash & Cash Equivalent Growth (%)	13.76	-27.14	-39.38	-6.48	124.14
Total Debt/ CFO (x)	0.02	0.05	0.03	0.00	0.06

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	63.24	39.16	76.18	71.41	70.71
Net Cash used in Investing Activities	-57.34	-36.64	-78.08	-64.91	-28.99
Net Cash flow from Financing Activities	-5.18	-4.50	-2.56	-5.29	-38.10
Net Cash Flow	0.73	-1.99	-4.46	1.20	3.61
Closing Cash & Cash Equivalent	5.31	4.58	6.57	10.13	8.92
Closing Cash & Cash Equivalent Growth (%)	15.84	-30.25	-35.14	13.48	68.06
Total Debt/ CFO (x)	0.02	0.05	0.03	0.00	0.06

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	15.73	14.50	16.02	16.58	16.42
Return on Capital Employed (%)	20.34	19.89	21.94	22.10	21.38
Return on Assets (%)	13.32	12.41	12.97	13.54	13.21
Interest Coverage Ratio (x)	91.70	55.01	72.68	54.60	34.32
Asset Turnover Ratio (x)	0.90	0.91	0.95	92.34	99.25
Price to Earnings (x)	12.58	9.31	8.98	7.23	5.20
Price to Book (x)	1.98	1.35	1.44	1.20	0.85
EV/EBITDA (x)	8.63	5.79	5.45	4.70	3.37
EBITDA Margin (%)	23.13	21.88	22.34	21.88	19.81

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	15.73	14.50	16.02	16.55	16.27
Return on Capital Employed (%)	20.34	19.89	21.93	22.12	21.18
Return on Assets (%)	13.32	12.41	12.98	13.76	13.49
Interest Coverage Ratio (x)	91.84	55.03	72.69	61.29	33.29
Asset Turnover Ratio (x)	0.90	0.91	0.97	1.03	102.41
Price to Earnings (x)	12.58	9.31	8.98	7.44	5.40
Price to Book (x)	1.98	1.35	1.44	1.23	0.88
EV/EBITDA (x)	8.64	5.79	5.75	4.96	3.65
EBITDA Margin (%)	23.13	21.87	22.34	21.33	19.01

Financial InsightsLincoln Pharma

Income (P&L)
Cash Flow

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 17.72% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
- Cash from Operations vs PAT
  Operating cash flow of Rs 63.22 cr is 0.68 times compared to the reported net profit of Rs 93.3 cr. (Source: Consolidated Financials)
- Increase in Cash from Investing
  Company has used Rs 57.34 cr for investing activities which is an YoY increase of 56.49%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Lincoln Pharma Share Price Forecast

Get multiple analysts’ prediction on Lincoln Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Lincoln Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Lincoln Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Lincoln Pharma Technicals

Stock doesn't have any Buy/Sell Signals.
Price Analysis Data details are not available.
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic - - - - - - -
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR - - -

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	-	-	-	-	-	-	-

	5 DAYS	14 DAYS	28 DAYS
ATR	-	-	-

Lincoln Pharma Peer Comparison

CHART
TABLE

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 78.82% as compared to Nifty Smallcap 100 which gave a return of 71.75%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 78.82% return as compared to Nifty Pharma which gave investors 67.4% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Lincoln Pharma Stock Performance	-0.43	-0.56	4.18	-24.67	-1.09	76.41	286.28
Solara Active Pharma Stock Performance	4.02	1.41	-1.68	-6.20	-0.91	2.95	6.75
SMS Pharma Stock Performance	0.94	2.58	16.36	11.17	16.68	152.77	501.42
Amrutanjan Health Care Stock Performance	2.80	0.59	11.33	6.24	-9.78	-17.74	99.09
Syncom Form Stock Performance	-2.22	-5.15	-7.03	-16.10	16.39	0.00	0.00
Add More

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 78.82% as compared to Nifty Smallcap 100 which gave a return of 71.75%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 78.82% return as compared to Nifty Pharma which gave investors 67.4% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Lincoln Pharma	12.65	1.91	15.73	20.34	13.32	12.55	21.30	16.07	46.58	4.84	0.00	0.02
Solara Active Pharma	-9.52	2.57	-60.75	-17.42	-24.13	-7.62	-14.98	-43.98	-157.62	0.64	1.07	9.18
SMS Pharma	32.43	4.00	9.29	12.75	4.81	7.91	12.62	6.93	5.89	1.62	0.52	5.59
Amrutanjan Health Care	40.94	7.00	15.58	20.91	12.25	8.25	14.74	10.67	15.50	4.23	0.00	0.00
Syncom Form	37.17	5.04	8.78	12.89	6.25	3.17	14.59	9.61	0.34	2.58	0.25	-12.17
Add More

Annual Ratios (%)

Choose from Peers

Jagsonpal Pharm
Bliss GVS Pharma
Themis Medicare
Kopran Ltd
Anuh Pharma

Choose from Stocks

See All Parameters

Peers InsightsLincoln Pharma

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 78.82% as compared to Nifty Smallcap 100 which gave a return of 71.75%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 78.82% return as compared to Nifty Pharma which gave investors 67.4% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Lincoln Pharma Shareholding Pattern

Loading...
Showing Lincoln Pharma Shareholding as on Mar 2025
Category Mar 2025 Dec 2024 Sep 2024 Jun 2024
Promoters 49.78 49.78 49.78 49.78
Pledge 0.00 0.00 0.00 0.00
FII 5.00 5.16 5.18 3.95
DII 0.00 0.00 0.00 0.04
Mutual Funds 0.00 0.00 0.00 0.00
Others 45.22 45.06 45.04 46.23
Showing Shareholding as on Mar 2025
Category No. of Shares Percentage % Change QoQ
Promoters 99,69,930 49.78 % 0.00
Pledge 0 0.00 % 0.00
FII 10,00,601 5.00 % -0.16
DII 1,232 0.00 % 0.00
MF 349 0.00 % 0.00
Others 90,57,965 45.22 % 0.15

Category	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Promoters	49.78	49.78	49.78	49.78
Pledge	0.00	0.00	0.00	0.00
FII	5.00	5.16	5.18	3.95
DII	0.00	0.00	0.00	0.04
Mutual Funds	0.00	0.00	0.00	0.00
Others	45.22	45.06	45.04	46.23

Category	No. of Shares	Percentage	% Change QoQ
Promoters	99,69,930	49.78 %	0.00
Pledge	0	0.00 %	0.00
FII	10,00,601	5.00 %	-0.16
DII	1,232	0.00 %	0.00
MF	349	0.00 %	0.00
Others	90,57,965	45.22 %	0.15

Lincoln Pharma MF Ownership

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- -1.83
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.04%
  % of AUM
- -2.19
  % Change (MoM basis)

MF Ownership as on 31 March 2025

View all Mutual Fund Schemes

Lincoln Pharma Corporate Actions

Meeting Date	Announced on	Purpose	Details
Feb 13, 2025	Feb 05, 2025	Board Meeting	Quarterly Results
Nov 14, 2024	Nov 05, 2024	Board Meeting	Quarterly Results
Sep 30, 2024	Sep 02, 2024	AGM	Rs.1.8000 per share(18%)Final Dividend
Aug 08, 2024	Jul 30, 2024	Board Meeting	Quarterly Results
May 16, 2024	May 08, 2024	Board Meeting	Audited Results & Final Dividend

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	18%	1.8	Sep 13, 2024	May 16, 2024
Final	15%	1.5	Sep 15, 2023	May 25, 2023
Final	15%	1.5	Sep 15, 2022	May 19, 2022
Final	15%	1.5	Sep 16, 2021	May 25, 2021
Interim	15%	1.5	Mar 05, 2020	Feb 24, 2020

All Types Ex-Date Record Date Announced on Details
Splits Mar 19, 2009 Mar 26, 2009 Sep 30, 2008 Split: Old FV2.0| New FV:10.0
Splits Feb 08, 2006 Feb 16, 2006 Dec 19, 2005 Split: Old FV10.0| New FV:2.0

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Mar 19, 2009	Mar 26, 2009	Sep 30, 2008	Split: Old FV2.0\| New FV:10.0
Splits	Feb 08, 2006	Feb 16, 2006	Dec 19, 2005	Split: Old FV10.0\| New FV:2.0

About Lincoln Pharma

Lincoln Pharmaceuticals Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 1,130.38 Crore) operating in Pharmaceuticals sector. Lincoln Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceutical Products, Export Incentives, Job Work, Sale of services and Scrap for the year ending 31-Mar-2024. Show More

Executives
Auditors

KM
Kishor M Shah
Non Executive Chairman
MG
Mahendra G Patel
Managing Director
AR
Ashish R Patel
Whole Time Director
HI
Hashmukh I Patel
Whole Time Director
MM
Munjal M Patel
Whole Time Director
RG
Rajnikant G Patel
Non Executive Director
NS
Nareshkumar Suthar
Independent Director
SJ
Saurin J Parikh
Independent Director
SM
Seema Mehta
Independent Director
DA
Darshit A Shah
Chief Financial Officer
TK
Trusha K Shah
Co. Secretary & Compl. Officer
Show More
Samir M Shah & Associates
J T Shah & Co.

Industry

Pharma - Indian

Key Indices Listed on

BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more

Address

Lincoln House,Behind Satyam Complex,Ahmedabad, Gujarat - 380060

Contact

investor@lincolnpharma.com

http://www.lincolnpharma.com

More Details

FAQs about Lincoln Pharma share

1. What's Lincoln Pharma share price today and what are Lincoln Pharma share returns ?
Lincoln Pharma share price is Rs 564.35 as on 08 May, 2025, 03:44 PM IST. Lincoln Pharma share price is down by 0.43% based on previous share price of Rs 549.85. Lincoln Pharma share price trend:
- Last 1 Month: Lincoln Pharma share price moved up by 4.18%
- Last 3 Months: Lincoln Pharma share price moved down by 24.67%
- Last 12 Months: Lincoln Pharma share price moved down 1.09%
- Last 3 Years: Lincoln Pharma Share price moved up by 76.41%
2. Which are the key peers to Lincoln Pharma?
Top 10 Peers for Lincoln Pharma are Bliss GVS Pharma Ltd., Syncom Formulation (India) Ltd., NGL Fine - Chem Ltd., Jagsonpal Pharmaceuticals Ltd., SMS Pharmaceuticals Ltd., Amrutanjan Health Care Ltd., Anuh Pharma Ltd., Kopran Ltd., Themis Medicare Ltd. and Solara Active Pharma Sciences Ltd.
3. Who owns Lincoln Pharma?
Promoter, DII and FII owns 49.78, 0.0 and 5.16 shares of Lincoln Pharma as on 31 Mar 2025
- There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
- There is no change in Domestic Institutional Investors holding from 31 Dec 2024 to 31 Mar 2025
- Foreign Institutional Investors holding have gone down from 5.16 (31 Dec 2024) to 5.0 (31 Mar 2025)
- Other investor holding has gone up from 45.06 (31 Dec 2024) to 45.22 (31 Mar 2025)
4. What is the PE & PB ratio of Lincoln Pharma?
The PE ratio of Lincoln Pharma stands at 12.7, while the PB ratio is 1.91.
5. What are the Lincoln Pharma quarterly results?
On Consoldiated basis, Lincoln Pharma reported a total income and loss of Rs 155.52 Cr and Rs 20.77 respectively for quarter ending 2024-12-31. Total Income and profit for the year ending 2024-03-31 was Rs 614.97 Cr and Rs 93.30 Cr.
6. Who is the chairman of Lincoln Pharma?
Kishor M Shah is the Non Executive Chairman of Lincoln Pharma
7. How can I quickly analyze Lincoln Pharma stock?
Key Metrics for Lincoln Pharma are:
- PE Ratio of Lincoln Pharma is 12.65
- Price/Sales ratio of Lincoln Pharma is 2.02
- Price to Book ratio of Lincoln Pharma is 1.91
8. What are the returns for Lincoln Pharma share?
Return Performance of Lincoln Pharma Shares:
- 1 Week: Lincoln Pharma share price moved down by 0.56%
- 1 Month: Lincoln Pharma share price moved up by 4.18%
- 3 Month: Lincoln Pharma share price moved down by 24.67%
- 6 Month: Lincoln Pharma share price moved down by 15.35%
9. What is the market cap of Lincoln Pharma?
Market Capitalization of Lincoln Pharma stock is Rs 1,130.38 Cr.
10. What has been highest price of Lincoln Pharma share in last 52 weeks?
52 Week high of Lincoln Pharma share is Rs 979.50 while 52 week low is Rs 499.00
11. What is the CAGR of Lincoln Pharma?
The CAGR of Lincoln Pharma is 8.16.
12. What dividend is Lincoln Pharma giving?
Lincoln Pharmaceuticals Ltd. announced an equity dividend of 18% on a face value of 10.0 amounting to Rs 1.8 per share on 16 May 2024. The ex dividend date was 13 Sep 2024.

Trending in Markets

Top Gainers As on 03:55 PM | 08 May 2025

Concord Biotech Ltd.1,523.00

126.41 (9.06%)

KPR Mill1,188.85

87.65 (7.96%)

Niva Bupa Health Ins87.30

6.27 (7.74%)

Crisil5,010.30

309.91 (6.60%)

Kirloskar Bros.1,840.00

93.71 (5.37%)

Top Losers As on 03:58 PM | 08 May 2025

CCL Products727.80

-44.81 (-5.80%)

Devyani Int172.61

-10.43 (-5.70%)

Poly Medicure2,674.80

-160.40 (-5.66%)

Torrent Power1,420.00

-81.91 (-5.46%)

Sundaram Finance4,985.50

-282.50 (-5.37%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	-1.14%
1 Week	-1.19%
1 Month	3.53%
3 Months	-25.19%
1 Year	-1.64%
3 Years	75.23%
5 Years	278.22%

ETPrime

Lincoln Pharmaceuticals Share Price

Lincoln Pharma share price insights

InsightsLincoln Pharma

Key Metrics

Key Metrics

Lincoln Pharma Share Price Returns

ET Stock ScreenersTop Score Companies

Lincoln Pharma News & Analysis

Lincoln Pharma Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Lincoln Pharma Share Recommendations

Recent Recos

Analyst Trends

Lincoln Pharma Financials

Insights

Insights

Financial InsightsLincoln Pharma

Lincoln Pharma Share Price Forecast

Get multiple analysts’ prediction on Lincoln Pharma

Get multiple analysts’ prediction on Lincoln Pharma

Get multiple analysts’ prediction on Lincoln Pharma

Lincoln Pharma Technicals

Pivot Levels

Average True Range

Lincoln Pharma Peer Comparison

Insights

Insights

Ratio Performance

Peers InsightsLincoln Pharma

Lincoln Pharma Shareholding Pattern

Lincoln Pharma MF Ownership

Motilal Oswal BSE Healthcare ETF-G

Bandhan BSE Healthcare Index Direct-G

Lincoln Pharma Corporate Actions

About Lincoln Pharma

Executives

Auditors

More Details

FAQs about Lincoln Pharma share

Trending in Markets

Top Gainers As on 03:55 PM | 08 May 2025

Top Losers As on 03:58 PM | 08 May 2025

Lincoln Pharma Quick Links

Equity Quick Links

More from Markets